Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wnt signaling: a win for bone.

Elke Piters1, Eveline Boudin, Wim Van Hul

  • 1Department of Medical Genetics, University and University Hospital Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium.

Archives of Biochemistry and Biophysics
|March 28, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Melanocortin 3 Receptors Do Not Specifically Localize to Primary Cilia in Cultured Human and Rodent Neurons.

Cell biochemistry and function·2026
Same author

The Paraoxonase (<i>PON</i>) Gene Family in Health, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Other Diseases.

International journal of molecular sciences·2025
Same author

The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracture.

Expert opinion on drug discovery·2025
Same author

Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration.

Clinical epigenetics·2025
Same author

Loss of the Ubiquitin-Associated Domain of sqstm1/p62 in Zebrafish Causes a Phenotype Resembling Paget's Disease of Bone.

Calcified tissue international·2025
Same author

A Case-Control Study Supports Genetic Contribution of the <i>PON</i> Gene Family in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease.

Antioxidants (Basel, Switzerland)·2024
Same journal

Sevoflurane preconditioning alleviates hypoxia-reoxygenation-induced myocardial injury via regulating the MIR210HG/miR-377-3p/PUM2 axis.

Archives of biochemistry and biophysics·2026
Same journal

Structural and kinetic analysis of human NQO1: Evidence for therapeutic inhibition by racemic warfarin.

Archives of biochemistry and biophysics·2026
Same journal

Mallotus japonicus leaf extract restores TRPM6 magnesium channel expression and suppresses cellular senescence in colonic epithelial cells.

Archives of biochemistry and biophysics·2026
Same journal

Sitosterol-Beta mitigates pulmonary hypertension by targeting SPHK1 in mice.

Archives of biochemistry and biophysics·2026
Same journal

Differential Regulation of Neuroinflammation and Tau Pathology by Apolipoprotein E3 and E4 via the mTORC1 Pathway: Implications for Alzheimer's Disease Risk.

Archives of biochemistry and biophysics·2026
Same journal

Hydrophilic/hydrophobic properties at the catalytic entrance of a magnesium-dechelatase homolog modulate catalytic efficiency in the magnesium extraction reaction.

Archives of biochemistry and biophysics·2026
See all related articles

Wnt signaling promotes bone formation by influencing osteoblast activity. Targeting this pathway, particularly sclerostin, offers potential for new osteoporosis treatments, despite potential side effects.

Area of Science:

  • Biochemistry
  • Developmental Biology
  • Bone Biology

Background:

  • Wnt signaling is crucial in embryonic development and adult life.
  • Canonical Wnt signaling is vital for bone formation, impacting osteoblast differentiation, proliferation, and apoptosis.
  • Non-canonical Wnt signaling also contributes to bone formation.

Purpose of the Study:

  • To highlight the therapeutic potential of Wnt signaling for osteoporosis treatment.
  • To address the challenge of Wnt pathway's pleiotropic functions and potential side effects.
  • To explore targeting sclerostin as a strategy for Wnt pathway modulation.

Main Methods:

  • Review of genetic studies on hereditary conditions.
  • Functional studies on Wnt signaling in bone formation.

Related Experiment Videos

  • Experimental analysis in animal models.
  • Investigation of sclerostin as a Wnt antagonist.

    • Main Results:

    • Wnt signaling demonstrates anabolic effects on bone by regulating (pre)osteoblasts and osteocytes.
    • Evidence confirms the role of both canonical and non-canonical Wnt pathways in bone formation.
    • Sclerostin identified as a bone-specific antagonist of canonical Wnt signaling.

    Conclusions:

    • Wnt signaling is a promising target for anabolic osteoporosis therapies.
    • Careful consideration of Wnt pathway's pleiotropic effects is necessary to avoid adverse outcomes.
    • Targeting sclerostin may offer a way to safely harness Wnt signaling for bone health.